Cite

HARVARD Citation

    Stolte, B. et al. (2018). Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. Therapeutic advances in neurological disorders. p. . [Online]. 
  
Back to record